Similar content being viewed by others
This article is cited by
-
Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model
Journal of Cancer Research and Clinical Oncology (2023)
-
HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development
Archivum Immunologiae et Therapiae Experimentalis (2020)
-
Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes
Medical Oncology (2014)